Hebei Senlang Biotechnology

About:

Hebei Senlang Biotechnology is focused on the treatment of immune cells new technology development and application of high-tech enterprises.

Website: http://www.senlangbio.com/en/

Top Investors: Qianhai Fund of Funds, Minyin International, Guochuang Investment, Hebei Xianchuang

Description:

Hebei Senlang Biotechnology is focused on the treatment of immune cells new technology development and application of high-tech enterprises.The company has the CAR-T research base (Senrang CAR-T Research Center) in North China, and has formed a high-barrier technology platform such as innovative CAR structural design, virus and cell culture , which can take into account technical research and development, hospital clinical application Provide high-quality and effective cellular immunotherapy support for hematological tumors, solid tumors and other tumor diseases, immune system diseases and other patients.